Public health

Championing Public Health

The UNC Gillings School of Global Public Health has been addressing the world’s biggest challenges for more than 80 years.

Ganga Bey

Ganga Bey is a postdoctoral researcher in the Department of Epidemiology within the UNC Gillings School of Global Public Health and a fellow in the Carolina Postdoctoral Program for Faculty Diversity. She studies how people’s beliefs about identity, worth, and ability affect their stress, aging, and susceptibility to disease.

Stopping Harm Before It Starts

Researchers at the UNC Injury Prevention Research Center began studying the long-term effects of injury and violence well before they were recognized as public health problems. For 30 years, they have addressed vital societal issues including domestic abuse, car crashes, traumatic brain injury, home and workplace safety, and opioid overdose — and have worked closely with practitioners to change policies and save lives.

Learning As We Go

Teachers are stressed. Students are struggling. Parents are shouldering more responsibilities than ever before. While the controversy surrounding when and how schools should reopen has led to policy debates and changes in family dynamics, UNC epidemiologists and education researchers find hope in the lessons from this year.

Tracking SARS-CoV-2 Variants

SARS-CoV-2 variants may seem like a scary new chapter in the pandemic, but coronavirus experts expected their arrival. Scientists in the UNC School of Medicine and Gillings School of Global Public Health are tracking the variants to learn how they differ and affect the world’s chance of ending this pandemic.

A Public Health Prognosis

Graduate student Rachel Woodul spent two years researching what might happen to hospital capacity when the next pandemic strikes. When it arrived, she compared what her model — and others’ — got wrong to improve how we react to public health crises in the future.

READDI, Not Reactive

For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.